Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2020-10-20 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于股东减持超过1%的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a shareholder announcement regarding a reduction in shareholding by a significant shareholder, Sun Jinzhong, who reduced his stake by over 1%. It details the shareholding percentages before and after the reduction, the methods of share disposal, and confirms compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The document is a notification of a major shareholding change, specifically a reduction exceeding 1%, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on this shareholding change, confirming it is not a full report or announcement of a report publication.
2020-10-20 Chinese
关于股份回购进展情况的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of a share repurchase program by the company 普莱柯生物工程股份有限公司. It details the board approval, repurchase price limits, repurchase volume, and total amount spent on buying back shares. The document does not contain financial statements or detailed financial analysis but focuses on the status and compliance of the share buyback plan. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2020-10-09 Chinese
第四届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司 (Pulike Bioengineering Co., Ltd.). It details the convening of the fourth board's eighth meeting, the attendance, and the voting results on specific agenda items such as related party investment and accounting policy changes. There is no financial data or detailed report content, only a summary of board decisions and references to further details on the stock exchange website. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and it is not a full report or financial statement, so it is not an Annual Report or Interim Report. Therefore, the classification is MANG with high confidence.
2020-09-14 Chinese
独立董事关于第四届董事会第八次会议的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the eighth meeting of the fourth board of directors, including related party transactions and accounting policy changes. It references compliance with company law and securities regulations, and it is a formal opinion rather than a full report or announcement of financial results. It does not contain financial statements or detailed financial data, nor is it a notice of voting results or a management report. This fits best under Board/Management Information (MANG), as it relates to board meeting decisions and director opinions.
2020-09-14 Chinese
第四届监事会第四次会议决议公告
Board/Management Information Classification · 90% confidence The document is a formal announcement of a resolution passed at the fourth meeting of the fourth Supervisory Board of the company 普莱柯生物工程股份有限公司. It details the meeting's convening, attendance, and the approval of a change in accounting policy according to Ministry of Finance regulations. There is no indication that this is a full audit report or annual report; rather, it is a board/committee meeting resolution announcement. The content focuses on governance and supervisory board decisions, which aligns with Board/Management Information filings. The document length is short and it is not a report publication announcement or certification. Therefore, the best fit is Board/Management Information (MANG).
2020-09-14 Chinese
关于根据财政部相关规定变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about a change in accounting policy in accordance with new accounting standards issued by the Ministry of Finance of China. It details the reasons for the change, the board and supervisory committee approvals, and the expected impact on financial statements. The document does not contain actual financial statements or detailed financial data but is a formal announcement of the policy change. It is relatively short (1648 characters) and serves as a regulatory announcement rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance-related announcement about accounting policy changes without substantive financial data.
2020-09-14 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.